Convalescent plasma therapy: Helpful treatment of COVID-19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications.
作者信息
Jiang Jipin, Miao Yan, Zhao Yuanyuan, Lu Xia, Zhou Ping, Zhou Xiaojun, Chen Zhishui, Du Dunfeng
机构信息
Institute of Organ Transplantation, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.
出版信息
Clin Transplant. 2020 Sep;34(9):e14025. doi: 10.1111/ctr.14025. Epub 2020 Jul 15.
Abstract
摘要
相似文献
1
Convalescent plasma therapy: Helpful treatment of COVID-19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications.
Clin Transplant. 2020 Sep;34(9):e14025. doi: 10.1111/ctr.14025. Epub 2020 Jul 15.
2
Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy.
Transpl Infect Dis. 2021 Feb;23(1):e13451. doi: 10.1111/tid.13451. Epub 2020 Sep 3.
3
Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with COVID-19 positive pneumonia: a case report.
Pan Afr Med J. 2021 Mar 16;38:273. doi: 10.11604/pamj.2021.38.273.28577. eCollection 2021.
4
Feasibility of Convalescent Plasma Therapy in Kidney Transplant Recipients With Severe COVID-19: A Single-Center Prospective Cohort Study.
Exp Clin Transplant. 2021 Apr;19(4):304-309. doi: 10.6002/ect.2020.0479. Epub 2021 Feb 17.
5
Successful Convalescent Plasma Therapy in a Child With Severe Coronavirus Disease.
Indian Pediatr. 2021 Jan 15;58(1):89-90. doi: 10.1007/s13312-021-2110-0. Epub 2020 Dec 1.
6
Efficacy of Convalescent Plasma to Treat Mild to Moderate COVID-19 in Kidney Transplant Patients: A Propensity Score Matching Analysis.
Transplantation. 2022 Jan 1;106(1):e92-e94. doi: 10.1097/TP.0000000000003962.
7
Convalescent Plasma Rescued a Severe COVID-19 Patient with Chronic Myeloid Leukemia Blast Crisis and Myelofibrosis.
Turk J Haematol. 2021 Feb 25;18(1):74-76. doi: 10.4274/tjh.galenos.2020.2020.0400. Epub 2020 Sep 29.
8
Treatment with convalescent plasma in solid organ transplant recipients with COVID-19: Experience at large transplant center in New York City.
Clin Transplant. 2020 Dec;34(12):e14089. doi: 10.1111/ctr.14089. Epub 2020 Sep 28.
9
The Second Wave of COVID-19 Disease in a Kidney Transplant Recipient Cohort: A Single-center Experience in Belgium.
Transplantation. 2021 Mar 1;105(3):e41-e42. doi: 10.1097/TP.0000000000003596.
10
Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?
Med Hypotheses. 2020 Nov;144:109903. doi: 10.1016/j.mehy.2020.109903. Epub 2020 May 31.
引用本文的文献
1
Convalescent plasma for people with COVID-19: a living systematic review.
Cochrane Database Syst Rev. 2023 May 10;5(5):CD013600. doi: 10.1002/14651858.CD013600.pub6.
2
Convalescent plasma for people with COVID-19: a living systematic review.
Cochrane Database Syst Rev. 2023 Feb 1;2(2):CD013600. doi: 10.1002/14651858.CD013600.pub5.
3
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2023 Jan 3;6(1):e2250647. doi: 10.1001/jamanetworkopen.2022.50647.
4
'Convalescent Plasma'- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review.
Infect Disord Drug Targets. 2022;22(8):42-60. doi: 10.2174/1871526522666220425103031.
5
Coronavirus-19 infection in kidney transplant recipients: A comprehensive review.
Indian J Urol. 2022 Apr-Jun;38(2):110-114. doi: 10.4103/iju.iju_430_21. Epub 2022 Apr 1.
6
Perplexing issues for convalescent immune plasma therapy in COVID-19.
North Clin Istanb. 2021 Nov 15;8(6):634-643. doi: 10.14744/nci.2021.73604. eCollection 2021.
7
Immunological effects of convalescent plasma therapy for coronavirus: a scoping review.
BMC Infect Dis. 2021 Dec 24;21(1):1278. doi: 10.1186/s12879-021-06981-0.
8
SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020.
Transplant Proc. 2021 Oct;53(8):2421-2434. doi: 10.1016/j.transproceed.2021.08.019. Epub 2021 Aug 16.
9
Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with COVID-19 positive pneumonia: a case report.
Pan Afr Med J. 2021 Mar 16;38:273. doi: 10.11604/pamj.2021.38.273.28577. eCollection 2021.
10
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic.
Liver Transpl. 2021 Sep;27(9):1312-1325. doi: 10.1002/lt.26194. Epub 2021 Jul 31.
本文引用的文献
1
A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals.
JAMA. 2020 Aug 4;324(5):455-457. doi: 10.1001/jama.2020.10218.
2
Covid-19 and Kidney Transplantation.
N Engl J Med. 2020 Jun 18;382(25):2475-2477. doi: 10.1056/NEJMc2011117. Epub 2020 Apr 24.
3
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
J Korean Med Sci. 2020 Apr 13;35(14):e149. doi: 10.3346/jkms.2020.35.e149.
4
Convalescent plasma as a potential therapy for COVID-19.
Lancet Infect Dis. 2020 Apr;20(4):398-400. doi: 10.1016/S1473-3099(20)30141-9. Epub 2020 Feb 27.
5
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
6
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16.
Zotero 插件